Study title:
Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.Yoshikawa N, Honda M, Iijima K, Awazu M, Hattori S, Nakanishi K, Ito H; Japanese Pediatric IgA Nephropathy Treatment Study Group.
Clin J Am Soc Nephrol. 2006 May;1(3):511-7.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Immune System Diseases
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: Azathioprine |
ATC code: L04AX01 |
Document link:
|
Document date: 2015-04-14
|
Study number: PMID: 17699253
|
EudraCT number:
|
Scope of study: CLINICAL |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|